Instabilities in a Two-Component, Species Conserving Condensate

We consider a system of two species of bosons of equal mass, with interactions $U^{a}(|x|)$ and $U^{x}(|x|)$ for bosons of the same and different species respectively. We present a rigorous proof -- valid when the Hamiltonian does not include a species switching term -- showing that, when $U^{x}(|x|)>U^{a}(|x|)$, the ground state is fully "polarized" (consists of atoms of one kind only). In the unpolarized phase the low energy excitation spectrum corresponds to two linearly dispersing modes that are even a nd odd under species exchange. The polarization instability is signaled by the vani shing of the velocity of the odd modes.Comment: To appear in Phys. Rev.

Charming penguin contributions to charmless B decays into two pseudoscalar mesons

We present estimates of the charming penguin contribution to B => K pi, pi pi,K eta, K eta' decays due to intermediate charmed meson states. We find that this contribution is indeed significant for B => K pi decays, and its inclusion, together with the tree and penguin terms, produces large branching ratios in agreement with data, though the analysis is affected by large theoretical uncertainties. On the other hand, for B => pi pi, K eta, K eta' decays, the effect of the charming penguin contribution is more modest. We also compute CP asymmetries for B => K pi, pi pi decays and we obtain rather large results.Comment: 12 pages, 4 figures, LaTeX2e with epsfig. Minor changes in the text, this version will appear in Phys. Rev.

Negatively Charged Excitons and Photoluminescence in Asymmetric Quantum Well

We study photoluminescence (PL) of charged excitons ($X^-$) in narrow asymmetric quantum wells in high magnetic fields B. The binding of all $X^-$ states strongly depends on the separation $\delta$ of electron and hole layers. The most sensitive is the ``bright'' singlet, whose binding energy decreases quickly with increasing $\delta$ even at relatively small B. As a result, the value of B at which the singlet--triplet crossing occurs in the $X^-$ spectrum also depends on $\delta$ and decreases from 35 T in a symmetric 10 nm GaAs well to 16 T for $\delta=0.5$ nm. Since the critical values of $\delta$ at which different $X^-$ states unbind are surprisingly small compared to the well width, the observation of strongly bound $X^-$ states in an experimental PL spectrum implies virtually no layer displacement in the sample. This casts doubt on the interpretation of PL spectra of heterojunctions in terms of $X^-$ recombination

Color Transparency versus Quantum Coherence in Electroproduction of Vector Mesons off Nuclei

So far no theoretical tool for the comprehensive description of exclusive electroproduction of vector mesons off nuclei at medium energies has been developed. We suggest a light-cone QCD formalism which is valid at any energy and incorporates formation effects (color transparency), the coherence length and the gluon shadowing. At medium energies color transparency (CT) and the onset of coherence length (CL) effects are not easily separated. Indeed, although nuclear transparency measured by the HERMES experiment rises with Q^2, it agrees with predictions of the vector dominance model (VDM) without any CT effects. Our new results and observations are: (i) the good agreement with the VDM found earlier is accidental and related to the specific correlation between Q^2 and CL for HERMES kinematics; (ii) CT effects are much larger than have been estimated earlier within the two channel approximation. They are even stronger at low than at high energies and can be easily identified by HERMES or at JLab; (iii) gluon shadowing which is important at high energies is calculated and included; (iv) our parameter-free calculations explain well available data for variation of nuclear transparency with virtuality and energy of the photon; (v) predictions for electroproduction of \rho and \phi are provided for future measurements at HERMES and JLab.Comment: Latex 57 pages and 17 figure

Integrating sequence and array data to create an improved 1000 Genomes Project haplotype reference panel

A major use of the 1000 Genomes Project (1000GP) data is genotype imputation in genome-wide association studies (GWAS). Here we develop a method to estimate haplotypes from low-coverage sequencing data that can take advantage of single-nucleotide polymorphism (SNP) microarray genotypes on the same samples. First the SNP array data are phased to build a backbone (or 'scaffold') of haplotypes across each chromosome. We then phase the sequence data 'onto' this haplotype scaffold. This approach can take advantage of relatedness between sequenced and non-sequenced samples to improve accuracy. We use this method to create a new 1000GP haplotype reference set for use by the human genetic community. Using a set of validation genotypes at SNP and bi-allelic indels we show that these haplotypes have lower genotype discordance and improved imputation performance into downstream GWAS samples, especially at low-frequency variants. © 2014 Macmillan Publishers Limited. All rights reserved

National identity predicts public health support during a global pandemic

Changing collective behaviour and supporting non-pharmaceutical interventions is an important component in mitigating virus transmission during a pandemic. In a large international collaboration (Study 1, N = 49,968 across 67 countries), we investigated self-reported factors associated with public health behaviours (e.g., spatial distancing and stricter hygiene) and endorsed public policy interventions (e.g., closing bars and restaurants) during the early stage of the COVID-19 pandemic (April-May 2020). Respondents who reported identifying more strongly with their nation consistently reported greater engagement in public health behaviours and support for public health policies. Results were similar for representative and non-representative national samples. Study 2 (N = 42 countries) conceptually replicated the central finding using aggregate indices of national identity (obtained using the World Values Survey) and a measure of actual behaviour change during the pandemic (obtained from Google mobility reports). Higher levels of national identification prior to the pandemic predicted lower mobility during the early stage of the pandemic (r = −0.40). We discuss the potential implications of links between national identity, leadership, and public health for managing COVID-19 and future pandemics.publishedVersio

Dexamethasone intravitreal implant in previously treated patients with diabetic macular edema : Subgroup analysis of the MEAD study

Background: Dexamethasone intravitreal implant 0.7 mg (DEX 0.7) was approved for treatment of diabetic macular edema (DME) after demonstration of its efficacy and safety in the MEAD registration trials. We performed subgroup analysis of MEAD study results to evaluate the efficacy and safety of DEX 0.7 treatment in patients with previously treated DME. Methods: Three-year, randomized, sham-controlled phase 3 study in patients with DME, best-corrected visual acuity (BCVA) of 34.68 Early Treatment Diabetic Retinopathy Study letters (20/200.20/50 Snellen equivalent), and central retinal thickness (CRT) 65300 \u3bcm measured by time-domain optical coherence tomography. Patients were randomized to 1 of 2 doses of DEX (0.7 mg or 0.35 mg), or to sham procedure, with retreatment no more than every 6 months. The primary endpoint was 6515-letter gain in BCVA at study end. Average change in BCVA and CRT from baseline during the study (area-under-the-curve approach) and adverse events were also evaluated. The present subgroup analysis evaluated outcomes in patients randomized to DEX 0.7 (marketed dose) or sham based on prior treatment for DME at study entry. Results: Baseline characteristics of previously treated DEX 0.7 (n = 247) and sham (n=261) patients were similar. In the previously treated subgroup, mean number of treatments over 3 years was 4.1 for DEX 0.7 and 3.2 for sham, 21.5 % of DEX 0.7 patients versus 11.1 % of sham had 6515-letter BCVA gain from baseline at study end (P = 0.002), mean average BCVA change from baseline was +3.2 letters with DEX 0.7 versus +1.5 letters with sham (P = 0.024), and mean average CRT change from baseline was -126.1 \u3bcm with DEX 0.7 versus -39.0 \u3bcm with sham(P < 0.001). Cataract-related adverse events were reported in 70.3 % of baseline phakic patients in the previously treated DEX 0.7 subgroup; vision gains were restored following cataract surgery. Conclusions: DEX 0.7 significantly improved visual and anatomic outcomes in patients with DME previously treated with laser, intravitreal anti-vascular endothelial growth factor, intravitreal triamcinolone acetonide, or a combination of these therapies. The safety profile of DEX 0.7 in previously treated patients was similar to its safety profile in the total study population